An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma
Clinical trial NCT03478657 · COMPLETED
Trial details
- NCT number
- NCT03478657
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-18
- Primary completion
- 2018-12-07
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.